GARRY ARTHUR NEIL
CIK 1586785 · Chief Executive Officer · last filed 2026-05-26
GARRY ARTHUR NEIL is a Chief Executive Officer who has filed 56 SEC Form 4 insider transactions across 9 companies since 2013. The most recent filing, for AVTX, was dated May 26, 2026. Across all open-market trades the lifetime net is +$619.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.81M
9
56
$619.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Chief Executive Officer | 190,314 | $14.76 | $2.81M | $29.6K | 12 | 2026-05-26 |
| CLDX | Director | — | $31.27 | — | $0 | 4 | 2025-06-09 |
| Zura Bio Ltd (ZURAW) Delisted | Director | — | $1.08 | — | $0 | 1 | 2023-05-22 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 0 | $99.99 | $0 | $0 | 7 | 2022-03-11 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Chief Scientific Officer | 81,372 | $2.93 | $238.4K | $20.7K | 5 | 2021-06-14 |
| Aevi Genomic Medicine, LLC (GNMX) Delisted | Chief Scientific Officer | 2,164,150 | — | — | $369.1K | 7 | 2019-12-09 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Director | 36,759 | — | — | $0 | 14 | 2019-01-03 |
| Aevi Genomic Medicine, LLC (MDGN) Delisted | Chief Scientific Officer | — | — | — | $0 | 1 | 2016-04-19 |
| Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Chief Scientific Officer | 39,774 | — | — | $200.0K | 4 | 2015-10-08 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | AVTX | Grant (A) | +100,200 | $0 | EDGAR |
| 2026-03-02 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2025-04-01 | AVTX | Mixed | +47,080 | -$150.5K | EDGAR |
| 2025-01-30 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2024-08-14 | AVTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | CLDX | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | AVTX | Buy (P) | +4,000 | $13.7K | EDGAR |
| 2023-05-22 | Zura Bio Ltd (ZURAW) Delisted | Grant (A) | — | $0 | EDGAR |